Protection from sepsis-induced acute renal failure by adenoviral-mediated gene transfer of β2-adrenoceptor

Nephrology Dialysis Transplantation

Volumn 25, Issue 3, 2010, Pages 730-737

  Nakamura, Akio ^a   Niimi, Ryo ^a   Yanagawa, Yukishige ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute renal failure; Adenovirus; Gene therapy; Sepsis; TNF

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN II; BETA 2 ADRENERGIC RECEPTOR; C REACTIVE PROTEIN; CANNABINOID 1 RECEPTOR; CD14 ANTIGEN; CYTOKINE; NITRIC OXIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; GENE DELIVERY SYSTEM; GENE TRANSFER; GLOMERULUS FILTRATION RATE; KIDNEY ARTERY STENOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL; TRANSGENE; WISTAR RAT;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD14; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE THERAPY; HUMANS; INJECTIONS, SUBCUTANEOUS; KIDNEY; KIDNEY FAILURE, ACUTE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, BETA-2; RENAL ARTERY OBSTRUCTION; SEPSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77649212126     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp561     Document Type: Article

References (32)

1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655
2. Schor N. Acute renal failure and the sepsis syndrome. Kidney Int 2002; 61: 764-776
3. Kikeri D, Pennel JP, Hwang KH, et al. Endotoxemic acute renal failure in awake rats. Am J Physio 1986; 250: F1098-F1106
4. Kaplan SL. Bacteremia and septic shock. Textbook of Pediatric Infectious Diseases. WB Saunders, Philadelphia 1998; 807-820
5. Nakamura A, Yanagawa Y. Pharmacogenomics and sepsis-induced renal failure: effects of β2-adrenoceptor function on the course of sepsis. Curr Parmacogen Personal Med 2008; 6: 98-107
6. Hetier P, Ayala J, Bousseau A, et al. Modulation of interleukin-1 and tumor necrosis factor expression by beta adrenergic agonists in mouse ameboid microgial cells. Exp Brain Res 1991; 86: 407-413
7. Severn A, Rapson NT, Hunter CA, et al. Regulation of tumor necrosis factor production by adrenaline and β2-adrenergic agonists. J Immunol 1992; 148: 3441-3445
8. Liao J, Keiser JA, Scales WE, et al. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 1995; 268: R896-R901
9. Nakamura A, Johns EJ, Imaizumi A, et al. Modulation of interleukin-6 by β2-adrenoceptor in endotoxin-stimulated renal macrophage. Kidney Int 1999; 56: 839-849
10. Nakamura A, Imaizumi A, Kohsaka T, et al. β2-adrenoceptor agonist suppresses tumor necrosis factor production in rat mesangial cells. Cytokine 2000; 12: 491-1484
11. Nakamura A, Johns EJ, Imaizumi A, et al. Activation of β2-adreno-ceptor prevents shiga toxin-induced tumour necrosis factor production. J Am Soc Nephrol 2001; 12: 2288-2299
12. Nakamura A, Imaizumi A, Yanagawa Y, et al. β2-adrenoceptor activation attenuates endotoxin-induced acute renal failure. J Am Soc Ne-phrol 2004; 15: 316-325
13. Nakamura A, Imaizumi A, Yanagawa Y, et al. Adenoviral delivery of the β2-adrenoceptor gene in sepsis. Clin Science 2005; 109: 503-511
14. Kypson AP, Peppel K, Akhter SA, et al. Ex vivo adenovirus-mediated gene transfer to the adult rat heart. J Thorac Cardiovasc Surg 1998; 115: 623-630
15. Zager RA. Escherichia coli endotoxin injections potentiate experimental ischemic renal injury. Am J Physiol 1986; 251: F988-F9
16. Basile DP., Fredrich K, Weihrauch D, et al. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am. J. Physiol 2004; 286: F893-F902
17. Mu W., Ouyang X, Agarwal A, et al. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal failure. J. Am. Soc Nephrol 2005; 16: 3651-3660
18. Mayer SE, Stull JT, Wastila WB. Rapid tissue fixation and extraction techniques. Methods Enzymo 1974; 38: 1-9
19. Koch WJ, Rockman HA, Samama P, et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 1995; 268: 1350-1353
20. Maurice LP, Hata JA, Shah AS, et al. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery. J Clin Invest 1999; 104: 21-29
21. Gluser MP, Zanetti G, Baumgartner JD, et al. Septic shock: pathoge-nesis. Lancet 1991; 338: 732-736
22. Kohan DE. Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 1994; 9: 73-77
23. Uddman E, Moller S, Adner M, et al. Cytokines induce increased en-dothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 1999; 376: 223-232
24. Tschaikowsky K, Sagner S, Lehnert N, et al. Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 2000; 28: 1854-1860
25. Kayama F, Yoshida T, Kodama Y, et al. Pro-inflammatory cytokines and interleukin-6 in the renal response to bacterial endotoxin. Cyto-kine 1997; 9: 688-695
26. Nakamura A, Johns EJ, Imaizumi A, et al. Effect of [2-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleu-kin-6 genes transcription in the rat renal resident macrophage cells. Cytokine 1999; 11: 759-765
27. Kaufmann A, Musset B, Limberg SH, et al. "Host tissue damage" signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes. J Biol Chem 2005; 280: 32459-324567
28. Daaka Y, Friedman H, Klein TW. Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation. J Pharmacol Exp Ther 1996; 276: 776-783
29. Nowicki B, Singhal J, Fang L, et al. Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice. Infect Immun 1999; 67: 2421-2427
30. Brizzolara-Gourdie A, Webb JG. Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agents. J Pharmacol Exp Ther 1997; 281: 354-359
31. Schutzer WE, Watts VJ, Chapman J, et al. Viral-mediated gene delivery of constitutively activated G alpha s alters vasoreactivity. Clin Exp Pharmacol Physiol 2000; 27: 9-13
32. Nakamura A, Johns EJ, Imaizumi A, et al. Role of angiotensin II-induced cAMP in mesangial TNF-alpha production. Cytokine 2002; 19: 47-51